USPTO serial 88321151
SPECTRUM THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- TMEG LAW OFFICE 108
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with SPECTRUM THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SMITH FALLS, ONTARIO, CA
Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica S. Sachs
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Terpenes, terpenoids, cannabidiol and cannabinoids, all derived from hemp in the following presentations: oral sprays, topical, capsules, tablets, tinctures, and creams, all for non-medical use | ACTIVE | — |
| 005 | Herbal and dietary supplements; Botanical supplements for use a dietary supplement; nutraceuticals for use a dietary supplement; health food supplements derived from hemp for medical purposes; nutritional supplements derived from hemp; hemp oil for medical purposes; shelled hemp seeds for medical purposes; hemp protein powder for medical purposes; hemp derivatives for medical purposes; herbal extracts for medicinal purposes; botanical supplements for general health and well-being for use as a dietary supplement; herbal supplements for general health and well- being for use as a dietary supplement; natural health food products derived from hemp for medical use; terpenes, terpenoids, cannabidiol, and cannabinoids derived from hemp in in the following presentations: concentrates, hashes, resins, shatter, oils, oral sprays, waxes, topicals, tonics, creams, pomades, ointments, capsules, patches, tablets, tinctures, suppositories, and balms, all for medical purposes; cigarettes containing tobacco substitutes derived from hemp for medical purposes; hemp protein powder for use as a dietary supplement; all of the aforementioned goods having a delta-9 tetrahydrocannabinol [THC] concentration of not more than 0.3 percent on a dry weight basis and also not containing CBD | ACTIVE | — |
| 029 | Edible oils containing hemp; edible butters containing hemp; hemp hearts for food; hemp oil for food; hemp-based snack foods; all of the aforementioned goods not containing CBD | ACTIVE | — |
| 034 | Hemp, hemp extracts and hemp derivatives, all for use as herbs for smoking and vaporizing; terpenes, terpenoids, cannabidiol and cannabinoids derived from hemp in the following presentations: concentrates, hashes, resins, shatter, for use as herbs for smoking and vaporizing; electronic cigarette liquid (e-liquid) containing hemp derivatives; cigarettes containing tobacco substitutes being hemp not for medical purposes; tobacco substitutes containing hemp; chemical flavoring in liquid form containing hemp used to refill electronic cigarette cartridges; flavorings for tobacco substitutes, other than essential oils, being hemp | ACTIVE | — |
| 035 | Wholesale, retail and online retail store services featuring pharmaceuticals, herbal and dietary supplements, botanical supplements, nutraceuticals, health food supplements derived from hemp, pharmaceuticals derived from hemp, nutritional supplements derived from hemp, hemp oil for medical purposes, shelled hemp seeds for medical, hemp protein powder for medical purposes, hemp derivatives, herbal extracts for medicinal purposes, botanical supplements for general health and well-being, herbal supplements for general health and well-being, natural health food products derived from hemp, cigarettes containing tobacco substitutes for medical purposes; wholesale, retail and online retail store services featuring terpenoids, cannabidiol, and cannabinoids derived from hemp in in the following presentations: concentrates, hashes, resins, shatter, oils, sprays, waxes, topicals, tonics, creams, pomades, ointments, capsules, patches, tablets, tinctures, suppositories, and balms, all for medical purposes; wholesale, retail and online retail store services featuring edible oils, edible butters, hemp protein powder, hemp hearts, hemp oil, hemp seeds, hemp flour, hemp cereal, hemp milk, hemp-based snack foods and other hemp products; all of the aforementioned services featuring goods having a delta-9 tetrahydrocannabinol [THC] concentration of not more than 0.3 percent on a dry weight basis and also not containing CBD | ACTIVE | — |
| 041 | Providing medical and health education services in the field of hemp, hemp extracts, and hemp derivatives, namely, seminars, lectures, audio-visual materials, written materials, courses, professional development, and training sessions; providing medical and health education services in the field of terpenes, terpenoids, cannabidiol and cannabinoids derived from hemp, namely, seminars, lectures, audio-visual materials, written materials, courses, professional development, and training sessions; providing medical and health education services in the field of pharmaceuticals and health supplements, namely, seminars, lectures, audio-visual materials, written materials, courses, professional development, and training sessions; providing medical and health education services in the field of natural health goods and nutraceuticals, namely, seminars, lectures, audio-visual materials, written materials, courses, professional development, and training sessions | ACTIVE | — |
| 044 | Providing medical and health information in the field of hemp, hemp extracts, and hemp derivatives terpenes, terpenoids, cannabidiol and cannabinoids via a website; providing medical and health information in the field of hemp, hemp extracts, and hemp derivatives terpenes, terpenoids, cannabidiol and cannabinoids for medical purposes via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TWEED INC.
- Other trademarks owned by Spectrum Cannabis Canada Ltd.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 034
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named SPECTRUM THERAPEUTICS
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 29, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 29, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 30, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 13, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 13, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 13, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 28, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 23, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 23, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 23, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 28, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 28, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 28, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 24, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 11, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 11, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 11, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 9, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 12, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 12, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 12, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 16, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 30, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 30, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 30, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 10, 2023 | ALIE | ASSIGNED TO LIE | — |
| Mar 3, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 14, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Dec 14, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Dec 14, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 13, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 9, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 9, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 9, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 9, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 9, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 9, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 5, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 2, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 2, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 2, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 25, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 19, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 14, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 14, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 14, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 18, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 23, 2020 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 23, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 23, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 23, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 23, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 22, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 22, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 22, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 22, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 17, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 17, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 17, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 17, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 17, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 17, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 17, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 17, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 17, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 17, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 31, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 31, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 4, 2019 | NWAP | NEW APPLICATION ENTERED | — |